In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting?

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of the American College of Cardiology

• Publication date

  2007-02-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JACC.2006.10.054PMID 17320742
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era.

  2006cited by this paper
• To cath or not to cath: that is no longer the question.

  2005cited by this paper
• Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials.

  2005cited by this paper
• Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes.

  2005cited by this paper
• Atherothrombosis and high-risk plaque: part I: evolving concepts.

  2005cited by this paper
• Diffuse coronary disease and atherothrombosis: a rationale for long-term therapy to prevent recurrent ischemic events.

  2003cited by this paper
• Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes.

  2002cited by this paper
• ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients

  2002cited by this paper
• Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

  2001cited by this paper
• Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.

  2001cited by this paper
• [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban].

  2001cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.

  2000cited by this paper
• Results (>6 months) of stenting of >1 major coronary artery in multivessel coronary artery disease.

  1999cited by this paper
• Procedural results and late clinical outcomes following multivessel coronary stenting.

  1998cited by this paper
• Long-term angiographic and clinical outcome of patients undergoing multivessel coronary stenting.

  1997cited by this paper
• Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease.

  1995cited by this paper
• Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty.

  1994cited by this paper
• Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.

  1988cited by this paper

• A riddle of culprit only vs multivessel or immediate vs staged revascularization in patients with non-ST elevation acute coronary syndrome: A meta-analysis

  2025cites this paper
• Fractional Flow Reserve-Guided Complete vs Culprit-Only Revascularization in Non-ST-Elevation Myocardial Infarction and Multivessel Disease: The SLIM Randomized Clinical Trial.

  2025cites this paper
• Complete Revascularization (CR) Versus Culprit‐Only Percutaneous Coronary Intervention (CO‐PCI) in NSTE‐ACS with Multivessel Disease: A Systematic Review and Meta‐Analysis

  2025cites this paper
• Multivessel versus culprit vessel only percutaneous coronary intervention in non-ST elevation myocardial infarction: Systematic review and meta-analysis

  2025cites this paper
• Multivessel revascularization in non-ST segment elevation acute coronary syndromes: A systematic review and meta-analysis of 182,798 patients.

  2024cites this paper
• Impact of Complete Revascularization for Acute Myocardial Infarction In Multivessel Coronary Artery Disease Patients With Diabetes Mellitus

  2024cites this paper
• Percutaneous coronary intervention strategies in non-ST segment elevation acute coronary syndrome patients with multivessel coronary artery disease: Systematic review pairwise and network meta-analysis.

  2024cites this paper
• Target Vessel Versus Complete Revascularization in Non-ST Elevation Myocardial Infarction Without Cardiogenic Shock

  2022cites this paper
• Multivessel versus Culprit-Only Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome

  2022cites this paper
• Completeness of revascularisation in acute coronary syndrome patients with multivessel disease.

  2021cites this paper
• Comparison of Different Timing of Multivessel Intervention During Index-Hospitalization for Patients With Acute Myocardial Infarction

  2021cites this paper
• Outcomes of Different Reperfusion Strategies of Multivessel Disease Undergoing Newer-Generation Drug-Eluting Stent Implantation in Patients with Non-ST-Elevation Myocardial Infarction and Chronic Kidney Disease

  2021cites this paper
• Manual der Arbeitsgruppe Interventionelle Kardiologie (AGIK) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK)

  2021cites this paper
• Long-Term Outcomes of Single-Vessel Percutaneous Coronary Intervention on Culprit Vessel vs. Multivessel Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Multivessel Coronary Artery Disease.

  2021cites this paper
• Total versus staged versus functional revascularization in NSTEACS patients with multivessel disease

  2021cites this paper
• Management of multivessel coronary artery disease in patients with non-ST-elevation myocardial infarction: a complex path to precision medicine

  2020cites this paper
• General glycosylated hemoglobin goals potentially increase myocardial infarction severity in diabetes patients with comorbidities: Insights from a nationwide multicenter study

  2020cites this paper
• Complete versus Staged Revascularization in Patients with Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Multivessel Disease

  2020cites this paper
• Correlation between Global Longitudinal Strain and Ischemic Burden from Myocardial Perfusion Imaging SPECT in Multivessel Stable Coronary Artery Disease Patients

  2020cites this paper
• Complete Revascularization in Acute and Chronic Coronary Syndrome.

  2020cites this paper
• Angiographic Complete versus Clinical Selective Incomplete Percutaneous Revascularization in Heart Failure Patients with Multivessel Coronary Disease

  2020cites this paper
• Optimal Revascularization Strategy in Non–ST‐Segment–Elevation Myocardial Infarction With Multivessel Coronary Artery Disease: Culprit‐Only Versus One‐Stage Versus Multistage Revascularization

  2020cites this paper
• Non-ST Elevation Myocardial Infarction: Diagnosis and Management

  2019cites this paper
• Completeness of Revascularization as a Determinant of Outcome: A Contemporary Review and Clinical Perspectives.

  2019cites this paper
• Meta-analysis Comparing Multivessel Versus Culprit Coronary Arterial Revascularization for Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.

  2019cites this paper
• Design and rationale of ischaemia-driven complete revascularisation versus usual care in patients with non-ST-elevation myocardial infarction and multivessel coronary disease: the South Limburg Myocardial Infarction (SLIM) trial

  2019cites this paper
• Identifying the Infarct-Related Artery in Patients With Non-ST-Segment-Elevation Myocardial Infarction.

  2019cites this paper
• JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome.

  2019cites this paper
• Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary Syndromes.

  2018cites this paper
• Revascularização multivaso versus revascularização da artéria culprit em pacientes com síndrome coronária aguda sem supradesnivelamento do segmento ST e doença coronária multivaso

  2018cites this paper
• I so wish it were true… “If it seems too good to be true, it probably is”

  2018cites this paper
• Early and long-term outcomes of complete revascularization with percutaneous coronary intervention in patients with multivessel coronary artery disease presenting with non-ST-segment elevation acute coronary syndromes

  2018cites this paper
• Continuum of Care for Acute Coronary Syndrome

  2018cites this paper
• The prognostic significance of incomplete revascularization and untreated coronary anatomy following percutaneous coronary intervention: An analysis of 6,755 patients with multivessel disease

  2018cites this paper
• Multivessel vs. culprit-only revascularization in patients with non-ST-elevation acute coronary syndromes and multivessel coronary disease.

  2018cites this paper
• Hypertension Is an Independent Predictor of Multivessel Coronary Artery Disease in Young Adults with Acute Coronary Syndrome

  2018cites this paper
• Revascularization Strategies in Multivessel Coronary Artery Disease

  2018cites this paper
• Is Complete Revascularisation Mandated for all Patients with Multivessel Coronary Artery Disease?

  2017cites this paper
• Multivessel vs. Culprit-Lesion-Stenting beim akuten Koronarsyndrom

  2017cites this paper
• DIRETRIZ DA SOCIEDADE BRASILEIRA DE CARDIOLOGIA E DA SOCIEDADE BRASILEIRA DE HEMODINÂMICA E CARDIOLOGIA INTERVENCIONISTA SOBRE INTERVENÇÃO CORONÁRIA PERCUTÂNEA

  2017cites this paper
• Optimal Timing of Complete Revascularization in Acute Coronary Syndrome: A Systematic Review and Meta‐Analysis

  2017cites this paper
• Staged versus One-Time Percutaneous Coronary Intervention Strategy for Multivessel Non-ST Segment Elevation Acute Coronary Syndrome

  2016cites this paper
• Incomplete Revascularization in Patients Treated With Percutaneous Coronary Intervention: When Enough Is Enough.

  2016cites this paper
• Nonobstructive Versus Obstructive Coronary Artery Disease in Acute Coronary Syndrome: A Meta‐Analysis

  2016cites this paper
• "One-Time" versus Staged Multivessel Intervention in Intermediate to Very High-Risk Patients with Non-ST-Segment Elevation Acute Coronary Syndromes

  2016cites this paper
• Staged versus “one-time” multivessel intervention in elderly patients with non-ST-elevation acute coronary syndrome

  2016cites this paper
• Multivessel versus Single Vessel Angioplasty in Non-ST Elevation Acute Coronary Syndromes: A Systematic Review and Metaanalysis

  2016cites this paper
• Complete myocardial revascularization confers a larger clinical benefit when performed with state‐of‐the‐art techniques in high‐risk patients with multivessel coronary artery disease: A meta‐analysis of randomized and observational studies

  2016cites this paper
• Optimal timing of invasive management in patients with non-ST-elevation acute coronary syndromes: still unresolved?

  2016cites this paper
• Treatment strategies of NSTEMI-ACS with multivessel disease

  2016cites this paper
• Multivessel Disease in the PCI Era: Where Is CABG?

  2016cites this paper
• PCI Strategies in Acute Coronary Syndromes without ST Segment Elevation (NSTEACS)

  2016cites this paper
• Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction.

  2016cites this paper
• Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial.

  2016cites this paper
• [2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)].

  2016cites this paper
• Culprit-Only vs. Complete Revascularization During ST-Segment Elevation Myocardial Infarction.

  2015influential citation
• Percutaneous Coronary Intervention and the Various Coronary Artery Disease Syndromes

  2015cites this paper
• Current approaches for the diagnosis, risk stratification and interventional treatment of patients with acute coronary syndromes without st-segment elevation

  2015cites this paper
• [2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation].

  2015cites this paper
• Do we really know the CvLPRIT in Myocardial infarction? or just stent all lesions?

  2015cites this paper
• 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment

  2015cites this paper
• Management of multivessel coronary disease in STEMI patients: a systematic review and meta-analysis.

  2015cites this paper
• Differences in coronary risk factors, procedural characteristics, mortality and stent thrombosis between two all-comers percutaneous coronary intervention registries from Europe and Japan: a patient-level data analysis of the Bern-Rotterdam and j-Cypher registries.

  2015cites this paper
• Wytyczne ESC dotyczące postępowania w ostrych zespołach wieńcowych bez przetrwałego uniesienia odcinka ST w 2015 roku Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw postępowania w ostrych zespołach wieńcowych bez przetrwałego uniesienia odcinka ST

  2015cites this paper
• Prognostic impact of multivessel versus culprit vessel only percutaneous intervention for patients with multivessel coronary artery disease presenting with acute coronary syndrome.

  2015cites this paper
• Meta-analysis of multivessel versus culprit-only percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome and multivessel coronary disease.

  2015cites this paper
• A comparison of multivessel and culprit vessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients with multivessel disease: a meta-analysis.

  2015cites this paper
• Percutaneous Intervention for Non-ST-Segment Elevation Acute Coronary Syndromes

  2015cites this paper
• Impact of completeness of revascularization by coronary intervention on exercise capacity early after acute ST-elevation myocardial infarction

  2014cites this paper
• Optimal treatment of multivessel complex coronary artery disease

  2014cites this paper
• 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cites this paper
• 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cites this paper
• Reperfusion Strategies in Acute Coronary Syndromes

  2014cites this paper
• 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cites this paper
• Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: analysis of over 4.400 patients in the EHS-PCI registry.

  2013cites this paper
• Prognostic value of stress hyperglycemia for in-hospital outcome in acute coronary artery disease.

  2013cites this paper
• The adequacy of myocardial revascularization in patients with multivessel coronary artery disease.

  2013cites this paper
• Residual SYNTAX score after PCI for triple vessel coronary artery disease: quantifying the adverse effect of incomplete revascularisation.

  2013cites this paper
• Admission wall motion score and quantitative ST-segment depression in the assessment of 30-day mortality in patients with first non-ST-segment elevation acute coronary syndromes.

  2013cites this paper
• Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome

  2013cites this paper
• How Should We Treat Multi-Vessel Disease in STEMI Patients?

  2013cites this paper
• Ad Hoc percutaneous coronary intervention: A consensus statement from the society for cardiovascular angiography and interventions

  2013cites this paper
• Early invasive strategy and outcomes of non-ST-elevation acute coronary syndrome patients: is time really the major determinant?

  2013cites this paper
• Staging of multivessel percutaneous coronary interventions: An expert consensus statement from the Society for Cardiovascular Angiography and Interventions

  2012cites this paper
• Complete versus incomplete revascularization for treatment of multivessel coronary artery disease in the drug-eluting stent era

  2012cites this paper
• Intervention for Non-ST-Segment Elevation Acute Coronary Syndromes

  2012cites this paper
• Resultados del empleo de la reserva fraccional de flujo en la valoración de lesiones no causales en el síndrome coronario agudo

  2012influential citation
• Percutaneous Coronary Intervention

  2012cites this paper
• Results of fractional flow reserve measurement to evaluate nonculprit coronary artery stenoses in patients with acute coronary syndrome.

  2012cites this paper
• Coronary Revascularization Strategy for ST Elevation Myocardial Infarction with Multivessel Disease: Experience and Results at 1-Year Follow-Up

  2011cites this paper
• Multivessel vs Single‐Vessel Revascularization in Patients With Non–ST‐Segment Elevation Acute Coronary Syndrome and Multivessel Disease in the Drug‐Eluting Stent Era

  2011cites this paper
• Clinical Decision Making Staging of Multivessel Percutaneous Coronary Interventions : an Expert Consensus Statement from the Society for Cardiac Angiography and Interventions

  2011cites this paper
• SÍNDROME CORONARIO AGUDO: ANGIOPLASTIA DE MÚLTIPLES VASOS VERSUS ANGIOPLASTIA DE LA ARTERIA CULPABLE

  2011cites this paper
• What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization.

  2011cites this paper
• Staged Complete Revascularization in ST-Segment Elevation Myocardial Infarction Should Be the Treatment of Choice Compared to Primary Complete Revascularization

  2011cites this paper
• Percutaneous coronary intervention for non ST-elevation acute coronary syndromes: which, when and how?

  2011cites this paper
• Outcomes from patients with multi‐vessel disease following primary PCI

  2011cites this paper
• 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

  2011cites this paper
• Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.

  2010cites this paper
• Controversies in non-ST-elevation acute coronary syndromes and percutaneous coronary interventions

  2010cites this paper